Patients Allege Connection Between Gynecomastia and Risperdal
Patients who were never told about the connection between gynecomastia and Risperdal are taking legal action to hold the manufacturers accountable.
Although there are side effects present with every different type of medication, male users of Risperdal say that they were never told about the connection between the development of gynecomastia and the use of the popular antipsychotic.
Risperdal has been approved to treat bipolar disorder in adults, schizophrenia in children and adults, and irritability linked to pediatric patients who have received a diagnosis of Autism.
The primary purpose of this antipsychotic is to minimize the side effects common in older types of drugs used to treat psychotic disorders.
Unfortunately, a growing number of patients who took the medication say that the manufacturers never told them about the connection between gynecomastia and Risperdal.
Johnson & Johnson and subsidiary Janssen Pharmaceuticals have been named in numerous lawsuits by those patients who say that they should have been warned about the link between gynecomastia and Risperdal well in advance of taking the medication.
Some of the men have developed significant breast growth and have had to undergo surgical procedures in order to remove it.
Risperdal was initially approved in 1993 by the FDA to treat adult schizophrenia. Additional uses for the drug were approved in 2006 and 2007.
The drug is often commonly prescribed off-label and those patients who have been treated even for approved uses claim that the link between gynecomastia and Risperdal is a strong one that can lead to breast development in juvenile males.
Gynecomastia is the official development of breast tissue in males. It is very troublesome in adults, but is also disturbing and can have life lasting emotional repercussions in children and juveniles.
In addition to the physical changes in the body, young men who develop gynecomastia may face significant psychological and emotional trauma. Prolactin inside Risperdal can stimulate breast tissue development.
Prolactin can also cause lactation in nursing and pregnant women.
Although women have high levels of prolactin, the hormone is usually very low in women who are not pregnant or nursing, prepubescent girls and males.
Stimulation of the pituitary gland can lead to high prolactin levels and those who allege a connection between gynecomastia and Risperdal claim that they should have been told about this serious side effect.
Gynecomastia is typically a permanent change for the male body, leading to the development of real breast tissue, different from what might be referred to as simple fat deposits.
This breast tissue can grow relatively quickly and may often only be removed through surgery, as the condition on its own will not go away when the drug is discontinued.
Men who dealt with the psychological and physical trauma of developing breasts may be eligible to pursue compensation through a lawsuit.
If you’ve experienced the connection between gynecomastia and Risperdal, schedule a consultation with the experienced attorneys at McDonald Worley today to learn more about your right to proceed with a lawsuit.